ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis

Speciality: Oncology


Speaker:

Dr. Srinivas K G | Medical Oncologist, MBBS, MD Paediatrics, DM Medical Oncology, Bharat Cancer Hospital

Description:

Dr. Srinivas K G presents a compelling retrospective analysis titled "ESMO Breast Cancer 2022: P REALITY X" in this insightful video. The discussion delves into the real-world efficacy and clinical outcomes of a specific breast cancer treatment regimen, as examined during the ESMO Breast Cancer 2022 conference. Dr. Srinivas meticulously reviews the data, highlighting key findings, patient responses, and the implications for future therapeutic strategies. His expertise provides valuable perspectives for oncologists and researchers seeking to optimize breast cancer management.

The video explores the retrospective study design, patient demographics, and survival outcomes analyzed in the P REALITY X trial. Dr. Srinivas emphasizes the importance of real-world evidence in complementing randomized clinical trials, offering a more comprehensive understanding of treatment effectiveness in diverse populations. He also addresses potential limitations and biases inherent in retrospective analyses, ensuring a balanced interpretation of the results. This session is a must-watch for medical professionals aiming to stay updated on the latest advancements in breast cancer research.

Dr. Srinivas K G’s detailed breakdown of the P REALITY X study serves as an invaluable resource for the oncology community. By bridging the gap between clinical trials and real-world practice, his analysis fosters a deeper appreciation for evidence-based decision-making. Stay tuned for more expert discussions and cutting-edge insights in upcoming videos. Your journey towards mastering breast cancer therapeutics continues here!
 


See More Webinars @ Hidoc Webinars





Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nearly 6 Million Deaths From Five Major Cancer Types Averted Since 1975

2.

Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.

3.

Interleukin-6 may boost prediction of obesity-related cancers

4.

Researchers use AI to monitor side effects of chemotherapy and support families dealing with pediatric cancer.

5.

As EGFR internalization is decreased, BUB1 controls EGFR signaling.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot